Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Curr Opin Anaesthesiol. 2022 Feb 1;35(1):42–47. doi: 10.1097/ACO.0000000000001077

Table 2.

Eurotransplant Heart Allocation System Tiers

International High Urgency Status
     ● Inotrope dependency
        ○ Meeting following 3 criteria for cardiac hypoperfusion syndrome
           ■ Signs and symptoms of terminal heart failure
           ■ Hemodynamic features
              ● Cardiac index < 2.0 L/min/m2
              ● Mixed venous saturation < 50%
              ● Pulmonary capillary wedge pressure > 15 mm Hg
           ■ Secondary organ damage (at least one of the following)
              ● Lactate above normal
              ● Bilirubin above normal
              ● Calculated GFR < 60 ml/min
              ● Serum sodium < 135 mmol/L
        ○ Meeting one of the following 2 criteria for inotrope dependency
           ■ When on continuous inotrope infusion with Dobutamine, Milrinone, or Enoximone for at least 72 hours
              ● Cardiac index stays < 2.0 L/min/m2 OR
              ● There is proof of decrease in cardiac index below 2.0 L/min/m2 when inotrope is weaned
           ■ Cardiac hypoperfusion syndrome within 14 days of a single infusion of Levosimendan
     ● Complications while on assist device
        ○ Assist device complication requiring device exchange OR
        ○ Infection on assist device with positive cultures or other proof (driveline infection excluded) OR
        ○ Repeated assist device related cerebral events demonstrated by CT scan
     ● Additional Special Cases
        ○ Primary graft failure within 1 week after transplant
National High Urgency Status
     ● Granted according to national policies
Normal Urgency Status
     ● Stable assist device or total artificial heart patients
     ● Stable heart failure patients not meeting urgency status criteria